Success in a Crowded Market: Pfizer and the Pandemic
When COVID-19 vaccines were in development in late 2020, Johnson & Johnson had the biggest advantage with U.S. consumers. After decades of successful branding of its baby products, the company had established a halo of trust with people across the country. Since the vaccines became available, J&J has also outspent its rivals, Pfizer and Moderna, …
Success in a Crowded Market: Pfizer and the Pandemic READ MORE